Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Alfred Valles

Cardiovascular Disease Fresno, CA Medical Doctor

NPI 1306919535 CMS profile 194943

1313 E Herndon Ave, Suite 102, Fresno, CA 93720

Open in the dashboard

General payments

$12,929

190 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Alfred Valles of Fresno, CA is reported in the CMS Open Payments database as having received $12,929 across 190 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 85th percentile of Cardiovascular Disease profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $64 3
2023 General $381 8
2022 General $2,255 27
2021 General $1,677 24
2020 General $859 17
2019 General $7,693 111

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Alfred Valles
  • Cardiovascular Disease median
  • Middle half of Cardiovascular Disease
  • National median

In program year 2025, general payments to Alfred Valles were reported at $64. Among 16,617 Cardiovascular Disease profiles paid that year, the median was $432 and the middle half received between $132 and $1,252.

Show as a table
Year Alfred Valles Cardiovascular Disease median Middle half National median
2019 $7,693 $450 $127–$1,392 $163
2020 $859 $242 $77–$751 $114
2021 $1,677 $335 $101–$1,037 $132
2022 $2,255 $395 $121–$1,211 $149
2023 $381 $443 $136–$1,283 $160
2024 $0 $450 $136–$1,323 $164
2025 $64 $432 $132–$1,252 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Edwards Lifesciences Corporation $3,835 36 payments
  2. Abbott Laboratories $2,668 26 payments
  3. Medtronic Vascular, Inc. $2,499 17 payments
  4. Abiomed $1,599 22 payments
  5. Amgen Inc. $647 36 payments
  6. Philips Electronics North America Corporation $500 1 payment
  7. Boston Scientific Corporation $245 7 payments
  8. Medtronic, Inc. $218 6 payments
  9. AstraZeneca Pharmaceuticals LP $140 4 payments
  10. Novartis Pharmaceuticals Corporation $104 7 payments
  11. Other $476 28 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $7,189 169 payments
  2. Travel and Lodging $5,102 16 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $500 1 payment
  4. Education $138 4 payments
Products named General payments · program years 2019–2025
  1. EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) $1,933 17 payments
  2. CoreValve Evolut $1,685 8 payments
  3. Impella $1,599 22 payments
  4. Xience V coronary stent system $1,528 7 payments
  5. Edwards SAPIEN 3 Transcatheter Heart Valve $1,069 4 payments
  6. Repatha $647 36 payments
  7. 3F $589 7 payments
  8. Spectranetics Undiv $500 1 payment
  9. Corlanor $223 13 payments
  10. MITRACLIP $187 2 payments
  11. Other $2,787 81 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

190 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Cardiovascular Disease in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record